HCA Healthcare, Inc. (LON:0J1R)

HCA Healthcare Statistics

Total Valuation

HCA Healthcare has a market cap or net worth of GBP 82.61 billion. The enterprise value is 119.39 billion.

Market Cap	82.61B
Enterprise Value	119.39B

Important Dates

The next estimated earnings date is Monday, January 26, 2026.

Earnings Date	Jan 26, 2026
Ex-Dividend Date	Sep 16, 2025

Share Statistics

Current Share Class	228.19M
Shares Outstanding	n/a
Shares Change (YoY)	-7.57%
Shares Change (QoQ)	-2.37%
Owned by Insiders (%)	1.17%
Owned by Institutions (%)	66.25%
Float	156.36M

Valuation Ratios

The trailing PE ratio is 17.50 and the forward PE ratio is 16.10.

PE Ratio	17.50
Forward PE	16.10
PS Ratio	1.49
PB Ratio	-51.43
P/TBV Ratio	n/a
P/FCF Ratio	13.72
P/OCF Ratio	8.65
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.67, with an EV/FCF ratio of 19.82.

EV / Earnings	25.30
EV / Sales	2.11
EV / EBITDA	9.67
EV / EBIT	13.44
EV / FCF	19.82

Financial Position

The company has a current ratio of 0.85

Current Ratio	0.85
Quick Ratio	0.64
Debt / Equity	n/a
Debt / EBITDA	2.86
Debt / FCF	5.72
Interest Coverage	5.28

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	12.20%
Return on Invested Capital (ROIC)	16.18%
Return on Capital Employed (ROCE)	27.80%
Revenue Per Employee	204,163
Profits Per Employee	17,415
Employee Count	316,000
Asset Turnover	1.25
Inventory Turnover	24.84

Taxes

In the past 12 months, HCA Healthcare has paid 1.48 billion in taxes.

Income Tax	1.48B
Effective Tax Rate	21.39%

Stock Price Statistics

The stock price has increased by +36.47% in the last 52 weeks. The beta is 1.38, so HCA Healthcare's price volatility has been higher than the market average.

Beta (5Y)	1.38
52-Week Price Change	+36.47%
50-Day Moving Average	427.86
200-Day Moving Average	372.27
Relative Strength Index (RSI)	71.80
Average Volume (20 Days)	813

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.56

Income Statement

In the last 12 months, HCA Healthcare had revenue of GBP 55.33 billion and earned 4.72 billion in profits. Earnings per share was 19.21.

Revenue	55.33B
Gross Profit	22.89B
Operating Income	8.65B
Pretax Income	6.91B
Net Income	4.72B
EBITDA	11.23B
EBIT	8.65B
Earnings Per Share (EPS)	19.21

Balance Sheet

The company has 811.64 million in cash and 34.48 billion in debt, giving a net cash position of -33.67 billion.

Cash & Cash Equivalents	811.64M
Total Debt	34.48B
Net Cash	-33.67B
Net Cash Per Share	n/a
Equity (Book Value)	-1.61B
Book Value Per Share	-17.27
Working Capital	-1.94B

Cash Flow

In the last 12 months, operating cash flow was 9.55 billion and capital expenditures -3.53 billion, giving a free cash flow of 6.02 billion.

Operating Cash Flow	9.55B
Capital Expenditures	-3.53B
Free Cash Flow	6.02B
FCF Per Share	n/a

Margins

Gross margin is 41.38%, with operating and profit margins of 15.64% and 8.53%.

Gross Margin	41.38%
Operating Margin	15.64%
Pretax Margin	12.50%
Profit Margin	8.53%
EBITDA Margin	20.30%
EBIT Margin	15.64%
FCF Margin	10.89%

Dividends & Yields

This stock pays an annual dividend of 2.13, which amounts to a dividend yield of 0.45%.

Dividend Per Share	2.13
Dividend Yield	0.45%
Dividend Growth (YoY)	5.82%
Years of Dividend Growth	4
Payout Ratio	10.75%
Buyback Yield	7.57%
Shareholder Yield	8.01%
Earnings Yield	5.71%
FCF Yield	7.29%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HCA Healthcare has an Altman Z-Score of 2.56 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.56
Piotroski F-Score	6